(D) in paragraph (4)(A)(i), by striking 
‘‘The coverage’’ and inserting ‘‘Subject to para-
graph (8), the coverage’’; and 
(E) by adding at the end the following new 
paragraph: 
‘‘(8) TREATMENT
OF
COST
SHARING
FOR 
ADULT VACCINES RECOMMENDED BY THE ADVISORY 
COMMITTEE
ON
IMMUNIZATION
PRACTICES
CON-
SISTENT
WITH
TREATMENT
OF
VACCINES
UNDER 
PART B.— 
‘‘(A) IN GENERAL.—For plan years begin-
ning on or after January 1 of the first year be-
ginning more than 60 days after the date of the 
enactment of this paragraph, the following shall 
apply with respect to an adult vaccine rec-
ommended by the Advisory Committee on Im-
munization Practices (as defined in subpara-
graph (B)): 
‘‘(i) NO
APPLICATION
OF
DEDUCT-
IBLE.—The deductible under paragraph 
(1) shall not apply with respect to such 
vaccine. 
‘‘(ii) NO
APPLICATION
OF
COINSUR-
ANCE.—There shall be no coinsurance 
VerDate Sep 11 2014 
01:20 Nov 26, 2019
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5076.IH
H5076
kjohnson on DSK79L0C42 with BILLS
under paragraph (2) with respect to such 
vaccine. 
‘‘(iii) NO
APPLICATION
OF
INITIAL 
COVERAGE
LIMIT.—The initial coverage 
limit under paragraph (3) shall not apply 
with respect to such vaccine. 
‘‘(iv) NO COST SHARING ABOVE AN-
NUAL
OUT-OF-POCKET
THRESHOLD.— 
There shall be no cost sharing under para-
graph (4) with respect to such vaccine. 
‘‘(B) ADULT VACCINES RECOMMENDED BY 
THE ADVISORY COMMITTEE ON IMMUNIZATION 
PRACTICES.—For purposes of this paragraph, 
the term ‘adult vaccine recommended by the 
Advisory Committee on Immunization Prac-
tices’ means a vaccine approved for use by 
adult populations and in accordance with rec-
ommendations of the Advisory Committee on 
Immunization Practices of the Centers for Dis-
ease Control and Prevention.’’. 
(3) CONFORMING AMENDMENTS TO COST SHAR-
ING
FOR
LOW-INCOME
INDIVIDUALS.—Section 
1860D–14(a) of the Social Security Act (42 U.S.C. 
1395w–114(a)) is amended— 
VerDate Sep 11 2014 
01:20 Nov 26, 2019
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5076.IH
H5076
kjohnson on DSK79L0C42 with BILLS
(A) in paragraph (1)(D), in each of clauses 
(ii) and (iii), by striking ‘‘In the case’’ and in-
serting ‘‘Subject to paragraph (6), in the case’’; 
(B) in paragraph (2)— 
(i) in subparagraph (D), by striking 
‘‘The substitution’’ and inserting ‘‘Subject 
to paragraph (6), the substitution’’; and 
(ii) in subparagraph (E), by striking 
‘‘subsection (c)’’ and inserting ‘‘paragraph 
(6) and subsection (c)’’; and 
(C) by adding at the end the following new 
paragraph: 
‘‘(6) NO APPLICATION OF COST SHARING FOR 
ADULT VACCINES RECOMMENDED BY THE ADVISORY 
COMMITTEE
ON
IMMUNIZATION
PRACTICES.—Con-
sistent with section 1860D–2(b)(8), for plan years 
beginning on or after January 1 of the first year be-
ginning more than 60 days after the date of the en-
actment of this paragraph, there shall be no cost 
sharing under this section with respect to an adult 
vaccine recommended by the Advisory Committee on 
Immunization Practices (as defined in subparagraph 
(B) of such section).’’. 
(c) STUDY AND REPORT.— 
VerDate Sep 11 2014 
01:20 Nov 26, 2019
Jkt 099200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H5076.IH
H5076
kjohnson on DSK79L0C42 with BILLS
(1) STUDY.—The Secretary of Health and 
Human Services (referred to in this subsection as 
the ‘‘Secretary’’), acting through the Director of the 
Centers for Disease Control and Prevention, and in 
collaboration with the Administrator of the Centers 
for Medicare & Medicaid Services, shall conduct a 
study on the uptake of vaccines among the Medicare 
beneficiary population, including the herpes zoster 
vaccine and the tetanus, diphtheria, and pertussis 
vaccine, and anticipated vaccines against such dis-
eases as respiratory syncytial virus, clostridium 
difficile, and others. Such study shall include an 
analysis of ways to— 
(A) increase the baseline target rate of 
coverage for vaccines recommended by the Advi-
sory Committee on Immunization Practices of 
the Centers for Disease Control and Prevention 
in the Healthy People 2020 goals; 
(B) ensure that baseline targets focus on 
reducing racial and socioeconomic disparities in 
the vaccine coverage rates for all adult vaccines; 
(C) help facilitate immunization of Medi-
care beneficiaries, by developing and evaluating 
a specific set of actions that will address physi-
cian and health care provider administrative 
VerDate Sep 11 2014 
01:20 Nov 26, 2019
Jkt 099200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H5076.IH
H5076
kjohnson on DSK79L0C42 with BILLS
challenges, such as difficulty verifying bene-
ficiary coverage and complexity of physician of-
fice billing of vaccines covered under Medicare 
part D, that impact access for beneficiaries; 
(D) support adoption of the HEDIS adult 
immunization status composite measure (Tdap, 
pneumococcal, influenza, and zoster) in order to 
close gaps in adult immunization performance 
measurement 
and 
incentivize 
vaccination 
through adoption of evidence-based measures; 
and 
(E) strengthen immunization information 
systems to allow all States to have electronic 
databases for immunization records. 
(2) REPORT.—Not later than 2 years after the 
date of enactment of this Act, the Secretary shall 
submit to Congress a report containing the results 
of the study under paragraph (1), together with rec-
ommendations for such legislation and administra-
tive action as the Secretary determines appropriate. 
Æ 
VerDate Sep 11 2014 
01:20 Nov 26, 2019
Jkt 099200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6301
E:\BILLS\H5076.IH
H5076
kjohnson on DSK79L0C42 with BILLS